PT  - JOURNAL ARTICLE
AU  - Sinclair, Heather Q.
ED  - Stone, Gregg
TI  - Selected Updates on Cardiometabolic Risk
DP  - 2009 Dec 01
TA  - MD Conference Express
PG  - 29--30
VI  - 9
IP  - 4
4099  - http://mdc.sagepub.com/content/9/4/29.short
4100  - http://mdc.sagepub.com/content/9/4/29.full
AB  - The metabolic syndrome (MetS) refers to a cluster of metabolic abnormalities that are caused by insulin resistance, which is often associated with intra-abdominal (visceral) obesity, a high-risk form of being overweight/obesity. Cardiometabolic risk encompasses overall cardiovascular disease (CVD) risk that results from traditional risk factors (age, sex, smoking, hypertension, LDL cholesterol, HDL cholesterol, diabetes) and from the additional risks of intra-abdominal obesity and related features of the MetS. Questions remain about the clinical implications of MetS and whether MetS contributes to global CVD risk. These issues were the focus of a special symposium that was organized by the International Chair on Cardiometabolic Risk at the 15th International Symposium on Atherosclerosis 2009 in Boston, Massachusetts, USA.